Skip to content

Author

Wei Wang

We have 2 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

A Strontium‐Based Polyphenol Nanozyme Reverses Cisplatin‐Related Acute Kidney Injury Through Near‐Infrared‐Enhanced PI3K/AKT Pathway Inhibition and Macrophage M2 Directional Polarization

Cisplatin‐related acute kidney injury (CP‐AKI) is a serious complication of cisplatin (CP) treated patients with cancer with high morbidity and mortality rates. It is directly related to the abnormal accumulation of CP in renal tubular epithelial cells, causing metabolic toxicity, DNA damage, and oxidative stress....

Ming-He Jiang, Rui-Kai Zhu, Shu-Rong Chen et al. · 0 citations
Aug 2026

Tetrandrine nanocrystals for rheumatoid arthritis: enhanced therapeutic efficacy associated with reduced JAK1 and STAT3 expression.

Tet-NCs provide superior therapeutic effects in RA compared to conventional Tet tablets, and their mechanism of action may involve the regulation of inflammation through inhibition of the JAK1/STAT3 signaling pathway.

Guang-Zhao Wang, Jian Mo, Wenxiu Huang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.